Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,175 | -6,356 | -3,655 | -15,309 | -8,578 |
| Depreciation Amortization | 787 | 498 | 300 | 751 | 1,176 |
| Accounts receivable | 2,203 | 494 | 1,101 | -1,683 | -1,662 |
| Other Working Capital | -147 | -1,098 | 1,327 | -2,514 | -3,268 |
| Other Operating Activity | -1,671 | 135 | -953 | 4,187 | 763 |
| Operating Cash Flow | $-7,003 | $-6,327 | $-1,880 | $-14,568 | $-11,569 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -655 | -659 | -611 | -1,161 | -852 |
| Net Acquisitions | N/A | N/A | N/A | 26,037 | 26,037 |
| Other Investing Activity | -4 | -4 | -4 | 207 | 214 |
| Investing Cash Flow | $-659 | $-663 | $-615 | $25,083 | $25,399 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -392 | -307 | -200 | -588 | -386 |
| Financing Cash Flow | $-392 | $-307 | $-200 | $-588 | $-386 |
| Exchange Rate Effect | 185 | 237 | 60 | -212 | -124 |
| Beginning Cash Position | 16,393 | 16,393 | 16,393 | 6,678 | 6,678 |
| End Cash Position | 8,524 | 9,333 | 13,758 | 16,393 | 19,998 |
| Net Cash Flow | $-7,869 | $-7,060 | $-2,635 | $9,715 | $13,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,003 | -6,327 | -1,880 | -14,568 | -11,569 |
| Capital Expenditure | -660 | -664 | -615 | -1,161 | -852 |
| Free Cash Flow | -7,663 | -6,991 | -2,495 | -15,729 | -12,421 |